TRANSCEND CAPITAL ADVISORS, LLC – AbbVie Inc. Transaction History
TRANSCEND CAPITAL ADVISORS, LLC portfolio value:
$3.10M
portfolio value
TRANSCEND CAPITAL ADVISORS, LLC quarter portfolio value change:
-12.37%
quarter
AbbVie Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.57% | 132 shares | -418K | $134.21 | 23.12K |
| Q2 2022 | share | Decrease | -1.47% | -343 shares | -261K | $153.16 | 22.99K |
| Q1 2022 | share | Increase | +3.61% | 813 shares | 733K | $162.11 | 23.33K |
| Q4 2021 | share | Increase | +2.84% | 623 shares | 652K | $135.93 | 22.52K |
| Q3 2021 | share | Increase | +13.62% | 2.62K shares | 224K | $106.6 | 21.9K |
| Q2 2021 | share | Increase | +8.01% | 1.43K shares | 238K | $110.09 | 19.27K |
| Q1 2021 | share | Decrease | -3.29% | -607 shares | -41K | $104.49 | 17.84K |
| Q4 2020 | share | Increase | +18.33% | 2.85K shares | 611K | $102.27 | 18.45K |
| Q3 2020 | share | Increase | +8.64% | 1.24K shares | -43K | $82.47 | 15.59K |
| Q2 2020 | share | Decrease | -19.58% | -3.49K shares | 46K | $91.35 | 14.35K |
| Q1 2020 | share | Decrease | -4.51% | -842 shares | -292K | $69.88 | 17.84K |
| Q4 2019 | share | Increase | 0.00% | 18.68K shares | 1.65M | $80.14 | 18.68K |